Literature DB >> 22935811

Rapid cVEMP and oVEMP responses elicited by a novel head striker and recording device.

P Ashley Wackym1, Jennifer A Ratigan, Jonathan D Birck, Steven H Johnson, Josef Doornink, Michael Bottlang, Stuart K Gardiner, F Owen Black.   

Abstract

OBJECTIVE: To develop a reliable, easy to use bedside, office, or field system that allows the rapid measurement of cervical and ocular vestibular evoked myogenic potentials (cVEMP and oVEMP) using a bone-conduction stimulus. STUDY
DESIGN: Prospective bioengineering design and proof of concept of the test system with saccular and utricular otolith response studies in human subjects.
SETTING: Private practice, tertiary neurotology referral center.
SUBJECTS: Twenty healthy adult controls without history of auditory or vestibular dysfunction and 5 preoperative and postoperative patients with confirmed superior canal dehiscence (SCD) participated.
INTERVENTIONS: The subjects underwent auditory stimuli-based cVEMP and oVEMP studies using a commercially available system as well as testing with a novel bone-conduction cVEMP and oVEMP head striker system. MAIN OUTCOME MEASURES: Duration of each study, healthy subject and patient comfort, reproducibility, latency, and amplitude of auditory and striker evoked cVEMP and oVEMP responses.
RESULTS: The mean age of the healthy controls was 43.8, with a range of 19 to 69 years (10 male and 10 female subjects). The mean age of the SCD patient group was 46, with a range of 25 to 54 years; all female subjects. Although the cVEMP responses were similar using either the auditory or head strike stimuli, the healthy subjects preferred the latter, but the SCD patients became more symptomatic. The oVEMP data showed more consistent responses using the striker system. A statistically significant reduction in latency for the striker-evoked cVEMP occurred compared with the auditory cVEMP evoked response in the 5 SCD preoperative patients. All normalized postoperatively.
CONCLUSION: Recording the cVEMP and oVEMP responses using the striker system was much more rapid than with auditory stimuli and was more comfortable for the healthy subjects. The striker system and the acoustic method elicited strong otolithic receptor dysfunction symptoms in all SCD patients; however, they preferred the shorter striker studies. The striker system, because of the statistically shorter latency of p13 during the striker evoked cVEMP, which normalized after SCD closure, suggests that this method may be useful in identifying SCD patients before imaging studies. In addition, based on our biomechanical data, the striker was able to reliably produce a consistent and defined head striker impact.

Entities:  

Mesh:

Year:  2012        PMID: 22935811     DOI: 10.1097/MAO.0b013e318268d234

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  10 in total

1.  Practice guideline: Cervical and ocular vestibular evoked myogenic potential testing: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Authors:  Terry D Fife; James G Colebatch; Kevin A Kerber; Krister Brantberg; Michael Strupp; Hyung Lee; Mark F Walker; Eric Ashman; Jeffrey Fletcher; Brian Callaghan; David S Gloss
Journal:  Neurology       Date:  2017-11-01       Impact factor: 9.910

2.  Big Stimulus, Little Ears: Safety in Administering Vestibular-Evoked Myogenic Potentials in Children.

Authors:  Megan L A Thomas; Denis Fitzpatrick; Ryan McCreery; Kristen L Janky
Journal:  J Am Acad Audiol       Date:  2017-05       Impact factor: 1.664

3.  Vestibular brain changes within 70 days of head down bed rest.

Authors:  Peng Yuan; Vincent Koppelmans; Patricia Reuter-Lorenz; Yiri De Dios; Nichole Gadd; Scott Wood; Roy Riascos; Igor Kofman; Jacob Bloomberg; Ajitkumar Mulavara; Rachael Seidler
Journal:  Hum Brain Mapp       Date:  2018-03-12       Impact factor: 5.038

4.  Air-Conducted Vestibular Evoked Myogenic Potential Testing in Children, Adolescents, and Young Adults: Thresholds, Frequency Tuning, and Effects of Sound Exposure.

Authors:  Amanda I Rodriguez; Megan L A Thomas; Kristen L Janky
Journal:  Ear Hear       Date:  2019 Jan/Feb       Impact factor: 3.570

5.  Comorbidities confounding the outcomes of surgery for third window syndrome: Outlier analysis.

Authors:  P Ashley Wackym; Heather T Mackay-Promitas; Shaban Demirel; Gerard J Gianoli; Martin S Gizzi; Dale M Carter; David A Siker
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-08-22

6.  Brain and Behavioral Evidence for Reweighting of Vestibular Inputs with Long-Duration Spaceflight.

Authors:  K E Hupfeld; H R McGregor; V Koppelmans; N E Beltran; I S Kofman; Y E De Dios; R F Riascos; P A Reuter-Lorenz; S J Wood; J J Bloomberg; A P Mulavara; R D Seidler
Journal:  Cereb Cortex       Date:  2022-02-08       Impact factor: 4.861

7.  Functional Brain Activation in Response to a Clinical Vestibular Test Correlates with Balance.

Authors:  Fatemeh Noohi; Catherine Kinnaird; Yiri DeDios; Igor S Kofman; Scott Wood; Jacob Bloomberg; Ajitkumar Mulavara; Rachael Seidler
Journal:  Front Syst Neurosci       Date:  2017-03-10

8.  Deactivation of somatosensory and visual cortices during vestibular stimulation is associated with older age and poorer balance.

Authors:  Fatemeh Noohi; Catherine Kinnaird; Yiri De Dios; Igor Kofman; Scott J Wood; Jacob J Bloomberg; Ajitkumar P Mulavara; Kathleen H Sienko; Thad A Polk; Rachael D Seidler
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

9.  Third Window Syndrome: Surgical Management of Cochlea-Facial Nerve Dehiscence.

Authors:  P Ashley Wackym; Carey D Balaban; Pengfei Zhang; David A Siker; Jasdeep S Hundal
Journal:  Front Neurol       Date:  2019-12-13       Impact factor: 4.003

10.  Longitudinal Cognitive and Neurobehavioral Functional Outcomes Before and After Repairing Otic Capsule Dehiscence.

Authors:  P Ashley Wackym; Carey D Balaban; Heather T Mackay; Scott J Wood; Christopher J Lundell; Dale M Carter; David A Siker
Journal:  Otol Neurotol       Date:  2016-01       Impact factor: 2.311

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.